These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 4313827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
    Fajans SS, Floyd JC, Thiffault CA, Knopf RF, Harrison TS, Conn JW.
    Ann N Y Acad Sci; 1968 Apr 11; 150(2):261-80. PubMed ID: 4299219
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The insulinomas].
    Andreani D, Tamburrano S, Tamburrano G, Natoli C.
    Minerva Med; 1979 Jun 16; 70(28):2029-30. PubMed ID: 221865
    [No Abstract] [Full Text] [Related]

  • 8. A morphological study on the mechanism of diazoxide-hyperglycemia (clinical and experimental investigation).
    Yoshinaga T.
    Endokrinologie; 1969 Jun 16; 54(5):410-22. PubMed ID: 4188182
    [No Abstract] [Full Text] [Related]

  • 9. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
    Loubatières A, Mariani MM, Alric R.
    Ann N Y Acad Sci; 1968 Apr 11; 150(2):226-41. PubMed ID: 4875709
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diazoxide and the secretion of insulin.
    Nutr Rev; 1972 Aug 11; 30(8):194-8. PubMed ID: 4340200
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of insulin release by diphenylhydantoin and diazoxide in a patient with benign insulinoma.
    Cohen MS, Bower RH, Fidler SM, Johnsonbaugh RE, Sode J.
    Lancet; 1973 Jan 06; 1(7793):40-1. PubMed ID: 4118560
    [No Abstract] [Full Text] [Related]

  • 16. [Normal histology of the beta-cells during insulin secretion].
    Bänder A.
    Acta Diabetol Lat; 1968 Oct 06; 5 Suppl 1():417-35. PubMed ID: 4907224
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Paradoxical enhancement of tolbutamide-induced insulin release by diazoxide in a patient with islet cell hyperplasia.
    Schikman CH, Chertow BS, Fariss BL.
    Acta Paediatr Scand; 1978 Sep 06; 67(5):671-6. PubMed ID: 358739
    [Abstract] [Full Text] [Related]

  • 19. Improvement in insulin secretion in diabetes after diazoxide.
    Greenwood RH, Mahler RF, Hales CN.
    Lancet; 1976 Feb 28; 1(7957):444-7. PubMed ID: 55717
    [Abstract] [Full Text] [Related]

  • 20. Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets.
    Song SH, Rhodes CJ, Veldhuis JD, Butler PC.
    Endocrinology; 2003 Aug 28; 144(8):3399-405. PubMed ID: 12865318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.